Archive: News
-
Marshall Recaps Milestones in CRC Paradigm
John L. Marshall, MD, recaps some of the biggest CRC advancements of 2017, and explains what those successes mean for the treatment paradigm moving forward.
Category: News
-
New GI Cancer Studies: Curious Failures, Hidden Gems
Dr. John Marshall on recent publications, both positive and negative, that may change your practice.
Category: News
-
Dr. Marshall Discusses Frontline Treatment for CRC
John L. Marshall, MD, discusses frontline treatment options for patients with colorectal cancer (CRC).
Category: News
-
Deciding the Duration of Adjuvant Chemotherapy in a Patient With Stage III Colon Cancer: When Can Less Be More?
Patients with stage III colon cancer benefit from adjuvant chemotherapy with FOLFOX or CAPOX.
Category: News
-
Clinical Trials Are ‘Too Damn Complicated’
Simplifying clinical research is possible and desirable, says Dr John Marshall.
Category: News
-
Sharing Innovation and Motivation at the Ruesch Center Symposium
Nearly 300 medical professionals, patients, caregivers and advocates attended the 8th Annual Ruesch Center Symposium on December 1, listening to lectures on topics including precision medicine, immunotherapy, proton therapy and molecular imaging.
Category: News
-
Addressing an Aching Need to do Something About Pancreatic Cancer
Jeanne Ruesch received the Margaret L. Hodges Leadership Award at the 31st annual Lombardi Gala on November 18 for her advocacy on behalf of research into pancreatic cancer and other cancers of the GI tract.
Category: News
-
Obstacles to Clinical Research
Dr. Marshall discusses the obstacles to global clinical research and how these may be overcome.
Category: News
-
Luminary Awards Honors CEO Julie Fleshman
On Dec. 1, OncLive® and The Ruesch Center for the Cure of Gastrointestinal Cancer, hosted the inaugural Luminary Awards in GI Cancer. Julie Fleshman, JD, MBA, PanCAN president and CEO, was honored at this event as well four other prominent figures in the GI community.
Category: News
-
Dr. Pishvaian Discusses Progress in Pancreatic Cancer
Michael Pishvaian, MD, PhD, director, Phase I Clinical Program, co-director of the Ruesch Center Pancreatic Cancer Program Medical Oncology, Otto J. Ruesch Center for the Cure of GI Cancer, Georgetown University Lombardi Comprehensive Cancer Center, discusses the progress that has been made in the treatment of patients with pancreatic cancer during the 2017 Ruesch Center Symposium.
Category: News